Briefing: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?

The FDA's 'breakthrough' designation for medical devices is increasingly favoring AI technologies that tackle a range of clinical issues rather than isolated problems.

This trend suggests a strategic pivot towards solutions that can enhance overall healthcare delivery, potentially improving patient outcomes through integrated approaches.

As AI continues to evolve, the implications for device architecture and operational throughput will be significant, necessitating careful consideration by developers and healthcare providers.